Working at The Binding Site

As one of the world’s leading specialised medical diagnostic companies, Binding Site provides an ideal environment to meet a wide range of career aspirations. Leading the way in delivering innovation to the market our employees meet some of the industry’s biggest challenges and opportunities head on. Our support of industry research and development ensures you can have the opportunity to drive innovation and improve patient lives worldwide.

Working at Binding Site means being part of a global community, encompassing a wide range of skills and knowledge. Our diverse workforce enables us to deliver new and innovative solutions to the market with shared ideas and a collective dedication to our mission, vision and values.

The Binding Site Group (TBSG) headquartered in Birmingham, UK specialises in the research, development, manufacture and sale of innovative medical diagnostic products, instrumentation and materials focused on Multiple Myeloma and other Immune system disorders. With over 25 years of expertise in antibody specificity technology, The Binding Site Group provides clinicians and laboratory staff with the tools to improve the diagnosis and management of patients across a range of immune system disorders.

The Company’s origins date back to a group of researchers from the Medical School of Birmingham University who first started looking at innovative ways of producing antibodies in the early 1970's. Today the Company is over 700 employees in the UK, over 1,000 globally and services over 3,000 customers in over 80 countries.

TBS currently has direct sales operations in the USA and UK, Germany, France, Italy, Spain, Portugal, Czech Republic and Benelux with remaining markets being served through an extensive network of distributors covering the rest of Europe, Asia and Latin America. Recently TBS has opened offices in Singapore, Australia, New Zealand, Japan, China, Eastern Europe and Brazil. The Company’s assays are approved for sale in over 80 countries worldwide including being CE marked in Europe and FDA approved in the USA.

The main site in Birmingham acts as the global headquarters and this includes; research and product development, manufacturing, global distribution, commercial, marketing and administrative functions. Direct sales and product support to customers in the UK are based here together with sales and technical support provided to our distributor network in over 80 countries.

The Binding Site: Facts and Figures

• Annual turnover of over £130 million (YE 30 Sept 2018) and good cash flows allow it to invest heavily in R&D and expansion of its production and commercial capabilities
• Double-digit growth (+15% CAGR 2011-2016) in a market where all the major competitors are growing in low single digits, if at all
• TBS has more than doubled its revenues in the last 5 years and has ambitious plans to repeat this over the next 5 years.
• We are at the forefront of research and development in our sector and this is recognised by the strong networks of scientific collaborators we have across the globe as well as winning the Queen’s award 3 times for export, innovation and international development.
• The ongoing expansion in the company means a significant number of vacancies are filled by internal promotions (over 25%) enabling employees to continue to develop their careers within TBS, even moving internationally.

Probably the friendliest and most collaborative bunch of people you will meet in this industry due to our collegiate feel as we were born out of the University of Birmingham